CLINICAL TRIAL FUNDING AGREEMENTClinical Trial Funding Agreement • May 16th, 2011 • Nile Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS CLINICAL TRIAL FUNDING AGREEMENT (this “Agreement”) is entered into as of February 25, 2011 (the “Effective Date”) between NILE THERAPEUTICS, INC., a Delaware company with offices at 4 West 4th Avenue, Suite 400, San Mateo, California 99402 (“Nile”) and MEDTRONIC, INC., a Minnesota corporation with offices at 710 Medtronic Parkway, Minneapolis, Minnesota 55432, U.S.A. (“Medtronic”) (each a “Party,” collectively the “Parties”).
CLINICAL TRIAL FUNDING AGREEMENTClinical Trial Funding Agreement • October 23rd, 2024 • Lumos Pharma, Inc. • Pharmaceutical preparations • Delaware
This Clinical Trial Funding Agreement (this “Agreement”) is made as of October 22, 2024 (the “Effective Date”) by and between Double Point Ventures LLC, a Delaware limited liability company (“Lender”) and Lumos Pharma, Inc., a Delaware corporation (“Borrower”).
